Specifically, the expression of PABPC1 in ESCC positively correlates with tumor differentiation, and high PABPC1 expression in ESCC patients is associated with shorter median survival time post-surgery compared to low PABPC1 expression (p = 0.043) (Zhang et al., 2022). Here, PABPC1 is linked to neoplasm.